Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.4.377

The usefulness of skin test in evaluation of immunity to varicella  

Kim, Ji-Young (Department of Pediatrics, College of Medicine, Hallym University)
Lee, Hye Jeen (Department of Pediatrics, College of Medicine, Hallym University)
Kim, Me Jin (Department of Pediatrics, College of Medicine, Hallym University)
Kim, Young Ho (Department of Pediatrics, College of Medicine, Hallym University)
Jung, Ji A (Department of Pediatrics, College of Medicine, Hallym University)
Yang, Seung (Department of Pediatrics, College of Medicine, Hallym University)
Hwang, Il Tae (Department of Pediatrics, College of Medicine, Hallym University)
Lee, Hae Ran (Department of Pediatrics, College of Medicine, Hallym University)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.4, 2008 , pp. 377-382 More about this Journal
Abstract
Purpose : The aim of this study is to assess the usefulness of skin test by an inactivated, 1/50 diluted solution of attenuated varicella vaccine in evaluating the immune status to varicella. Methods : Total 41 subjects (22 males, 19 females, aged 1-32 years) were enrolled from July to August, 2005. Past medical history including varicella infection, varicella vaccination were investigated through questionnaires. The skin test solution was prepared from solution of attenuated varicella vaccine(Oka strain) which was inactivated by exposure to room temperature for 10 days and diluted at 1/50 with normal saline. Skin test was done by injecting 0.1 mL of the solution intradermally into the volar surface of the right forearm and sterile normal saline was used as a control on the left forearm. Positive reaction was defined when the transverse diameter of the induration was 5 mm or more. Serum varicella zoster virus specific IgG antibody test by ELISA (enzyme-linked immunosorbent assay) was done. Results : In adults, the sensitivity of the varicella zoster virus skin test compared to ELISA was 94.7% and the positive predictive value was 100%. In children, both the positive predictive value and specificity were 100% but the sensitivity and the negative predictive value were 50% and 30.7% respectively. Children showed smaller skin test reactivity compared to adults. Conclusion : The varicella zoster virus skin test using inactivated, 1/50 diluted solution of attenuated varicella vaccine was proved as one of the useful tools for evaluating the immunity and susceptibility of the varicella zoster virus.
Keywords
Skin tests; Chickenpox; Immunity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gershon AA, Takahashi M, Seward J. Varicella vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders Co, 2004:783-823
2 Kelly PW, Petruccellin BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adults Americans to vaccine-preventable infections; a national serosurvey of US Army recruits. JAMA 1991;266:2724-9   DOI
3 Lee YE, Park EA, Kim KH. Varicella zoster virus specific IgG antibody titer in vaccinated and infected children, Korean J Pediatr 1996;39:934-42
4 Hambleton S. Chickenpox. Curr Opin Infect Dis 2005;18: 235-40   DOI   ScienceOn
5 Shiraki K, Yamanishi K, Takahashi M. Biological and immunological characterization of the soluble skin test antigen of varicella-zoster virus. J Infect Dis 1983;149:501-4
6 Kamiya H, Ihara T, Hattori A, Iwasa T, Sakurai M, Izawa T, et al. Diagnostic skin test reaction with varicella virus antigen and clinical application of the test. J Infect Dis 1977;136:784-8   DOI   ScienceOn
7 Ihara T, Kato T, Torigoe S, Oitani K, Isaji M, Ito M, et al. Antibody response determined with antibodv-depentent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization. Acta Paediatr Jpn 1991;33:43-9   DOI
8 Oh JK. Cost-benefit analysis of varicella vaccination in Korea(dissertation). Seoul: School of Public Health Seoul National University, 2002
9 Junker AK, Angus E, Thomas E. Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr Infect Dis J 1991;10:569-75   DOI   ScienceOn
10 Arvin AM. Varicella-zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 2001;4:442-9   DOI   ScienceOn
11 Baba K, Yabuuch H, Okuni H, Takahashi M. Studies with live varicella vaccine and inactivated skin test antigens; prospective effect of the vaccine and clinical application of the skin test. Pediatrics 1978;61:550-5
12 LaRussa P, Steinberg SP, Seeman MD, Gershon AA. Determination of immunity to varicella-zoster virus by means of an intradermal skin test. J Infect Dis 1985;152:869-75   DOI   ScienceOn
13 Alter SJ, Hammond JA, McVey CJ, Myers MG. Susceptibility to Varicella-zoster virus among adults at high risk for exposure. Am J Infect Control 1986;7:448-51   DOI
14 Berger R, Luescher D, Just M, D'Hondt E, Bogaert H. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster. Postgrad Med J 1985;61(4 Suppj):137S-141S
15 Centers for Disease Control. Varicella-Related Deaths-United stated, January 2003- June 2004. MMWR 2005:54: 272-4
16 Hayward A, Herberger M. Lymphocyte responses to varicella-zoster virus in the elderly. J Clin Immunol 1987;7:174-8   DOI
17 Korea Center for Disease Control and Prevention. Pediatric sentinel surveillance data on incidence of chickenpox. CDMR 2004;15:92
18 Centers for Disease Control. General recommendation on immunization. MMWR 1994;33(RR-1):1-37
19 Steele RW, Coleman MA, Fiser M, Bradsher RW. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility. Pediatrics 1982;70:604-8
20 Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90
21 Centers for Disease Control. Prevention of varicella. MMWR 1996:45 (RR-11):1-36
22 Baba K, Shiraki K, Kanesaki T, Yamanishi K, Oqra PL, Yabuuchi H, et al. Specificity of skin test with varicellazoster virus antigen in varicella-zoster and herpes simplex virus infections. J Clin Microbiol 1987;25:2193-6
23 Terada K, Kawano S, Shimada Y, Yagi Y, Kataoka N. Recurrent chickenpox after natural infection. Pediatr Infect Dis J 1996;15:179-81   DOI
24 Lee HR, Cha HS, Kim KH, editors. Health services research: Survey on efficacy and safety of varicella vaccine as a regular vaccine in Korea. Seoul; 2005. Contract Nr : NIP.05.13. Sponsored by Korea Center for Disease Control and Prevention
25 Somekh E, Bujanover G, Tal G, Dalal I, Tanay A, Lehman D. An intradermal skin test for determination of immunity to varicella. Arch Dis Child 2001;85:484-6   DOI
26 Takahashi M. Chickenpox virus. Adv Virus Res 1983;29:285-356
27 Williams DL, Gershon AA, Gelb LD, Spraker MK, Steinberg S, Ragab AH. Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia. J Pediatr 1985;106:259-61   DOI
28 Hambelton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev 2005;18:70-80   DOI   ScienceOn
29 Arbeter AM, Starr SE, Preblud SR, Ihara T, Paciorek PM, Miler DS, et al. Varicella vaccine trials in healthy children: a summary of comparative follow-up studies. Am J Dis Child 1984;138:434-8   DOI
30 Gershon AA, Steinberg SP, GeIb L. Clinical reinfection with varicella zoster virus. J Infect Dis 1984;149:137-42   DOI   ScienceOn
31 Sohn YM, Roh HO, Goo ML, Park BR, Park JH, Lim cj. Humoral and cell mediated immune response after immunization with varicella vaccine (OKA/LG). J Korean Pediatr Soc 1998:41:170-8
32 Takayama N, Minamitani M, Takayama M. High incidence of breakthrough varicella observed in healthy Japaneses children immunized with live attenuated varicella vaccine (Oka strain). Acta Paediatr Jpn 1997:39:663-8   DOI